You are here

Novartis

Novartis Drug Wins FDA Approval for Lung Cancers With Specific Mutation

Xconomy

Thu, 05/7/20 - 12:29 am

non-small cell lung cancer

Regeneron touts Eylea strength as Novartis rival falters, COVID-19 cuts demand

Fierce Pharma

Tue, 05/5/20 - 01:02 pm

The top pharma companies in social media

Fierce Pharma

Mon, 05/4/20 - 11:02 am

Boehringer Ingelheim

EMA gives thumbs up to key drugs from Novartis, Alexion, Vertex and more

Endpoints

Fri, 05/1/20 - 12:43 pm

Vertex Pharmaceuticals

Novartis spinout resTORbio reverse merges with T cell biotech after big PhIII failure

Endpoints

Wed, 04/29/20 - 10:31 am

Parkinson's Disease

Novartis to begin trial with canakinumab in COVID-19 pneumonia patients

Pharmaceutical Business Review

Wed, 04/29/20 - 10:21 am

clinical trials

Roche shares SMA data ahead of scrap with Biogen, Novartis

Fierce Biotech

Tue, 04/28/20 - 10:59 am

spinal muscular atrophy

clinical trials

#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions

Endpoints

Mon, 04/27/20 - 09:43 am

Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win

Fierce Pharma

Wed, 04/22/20 - 10:45 pm

clinical trials

graft vs host disease

FDA hastens development of Novartis’ Kymriah in follicular lymphoma

Pharmaforum

Wed, 04/22/20 - 10:35 am

follicular lymphoma

regenerative medicine

Early treatment with Novartis' Mayzent stalls secondary progressive MS: study

Fierce Pharma

Tue, 04/21/20 - 11:55 pm

multiple sclerosis

Novartis plans large-scale trial of COVID-19 drug hydroxychloroquine

Pharmaforum

Mon, 04/20/20 - 10:53 am

hydroxychloroquine

clinical trials

Novartis eyes a new market with its buyout of a small digital therapeutics player

Endpoints

Mon, 04/20/20 - 10:51 am

digital therapeutics

Incyte, Novartis launch drug study to treat coronavirus complication

Marketwatch

Sat, 04/18/20 - 11:22 pm

clinical trials

One of the best connected biotech startups in Boston snags a plum discovery deal with Novartis

Endpoints

Wed, 04/15/20 - 10:39 am

immuno-oncology

Eye drug side effects are real, Novartis confirms in new warning

BioPharma Dive

Thu, 04/9/20 - 11:15 pm

Roche’s risdiplam delay a relief for SMA rivals Biogen and Novartis—for now: analyst

Fierce Pharma

Wed, 04/8/20 - 11:03 am

Former Novartis exec wants to repurpose generic drugs to fight Covid-19

Stat

Tue, 04/7/20 - 10:15 am

drug repurposing

AbbVie, Pfizer, Novartis and more pledge millions in COVID-19 disaster relief

Fierce Pharma

Mon, 04/6/20 - 09:36 pm

Novartis cancels $1B sale of generics after antitrust concerns forced delays

Endpoints

Thu, 04/2/20 - 10:49 am

Pages